Cargando…
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature
RATIONALE: Hepatoid adenocarcinoma of lung (HAL) is a rare malignant tumor, which can be defined as a primary alpha-fetoprotein (AFP)-producing lung carcinoma. The majority of hepatoid adenocarcinoma (HAC) expressed AFP in tumor cells, but AFP expression is not required for its diagnosis according t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455993/ https://www.ncbi.nlm.nih.gov/pubmed/30946350 http://dx.doi.org/10.1097/MD.0000000000015053 |
_version_ | 1783409691811905536 |
---|---|
author | Yang, Kun Jiang, Huifeng Li, Qiuyao |
author_facet | Yang, Kun Jiang, Huifeng Li, Qiuyao |
author_sort | Yang, Kun |
collection | PubMed |
description | RATIONALE: Hepatoid adenocarcinoma of lung (HAL) is a rare malignant tumor, which can be defined as a primary alpha-fetoprotein (AFP)-producing lung carcinoma. The majority of hepatoid adenocarcinoma (HAC) expressed AFP in tumor cells, but AFP expression is not required for its diagnosis according to the modified diagnostic criteria. Despite that HAC exhibits a poor prognosis and ineffective treatment options, early diagnosis and aggressive treatment can result in long-term survival. PATIENT CONCERNS: We report a 70-year-old Chinese male patient with alcoholic intake over 30 years and smoking history of 60 cigarettes per day for 40 years. He sought medical consultation for productive cough and hemoptysis sputum. DIAGNOSES AND INTERVENTIONS: Chest CT scan revealed a mass (6.4 × 5.5 cm) in the left lower lobe of the lung. The patient underwent curative surgical resection, and subsequently diagnosed as HAL. OUTCOMES: Eighteen months after primary diagnosis, the patient died of multiple organ failure caused by distant metastases. LESSONS: Familiarizing with the clinical features and modified diagnostic criteria of this rare tumor may increase awareness of the disease among clinicians and pathologists, thereby avoiding misdiagnosis and mistreatment. |
format | Online Article Text |
id | pubmed-6455993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-64559932019-05-29 Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature Yang, Kun Jiang, Huifeng Li, Qiuyao Medicine (Baltimore) Research Article RATIONALE: Hepatoid adenocarcinoma of lung (HAL) is a rare malignant tumor, which can be defined as a primary alpha-fetoprotein (AFP)-producing lung carcinoma. The majority of hepatoid adenocarcinoma (HAC) expressed AFP in tumor cells, but AFP expression is not required for its diagnosis according to the modified diagnostic criteria. Despite that HAC exhibits a poor prognosis and ineffective treatment options, early diagnosis and aggressive treatment can result in long-term survival. PATIENT CONCERNS: We report a 70-year-old Chinese male patient with alcoholic intake over 30 years and smoking history of 60 cigarettes per day for 40 years. He sought medical consultation for productive cough and hemoptysis sputum. DIAGNOSES AND INTERVENTIONS: Chest CT scan revealed a mass (6.4 × 5.5 cm) in the left lower lobe of the lung. The patient underwent curative surgical resection, and subsequently diagnosed as HAL. OUTCOMES: Eighteen months after primary diagnosis, the patient died of multiple organ failure caused by distant metastases. LESSONS: Familiarizing with the clinical features and modified diagnostic criteria of this rare tumor may increase awareness of the disease among clinicians and pathologists, thereby avoiding misdiagnosis and mistreatment. Wolters Kluwer Health 2019-04-05 /pmc/articles/PMC6455993/ /pubmed/30946350 http://dx.doi.org/10.1097/MD.0000000000015053 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Yang, Kun Jiang, Huifeng Li, Qiuyao Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title | Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title_full | Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title_fullStr | Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title_full_unstemmed | Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title_short | Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature |
title_sort | primary pulmonary hepatoid adenocarcinoma: a case report and review of the literature |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455993/ https://www.ncbi.nlm.nih.gov/pubmed/30946350 http://dx.doi.org/10.1097/MD.0000000000015053 |
work_keys_str_mv | AT yangkun primarypulmonaryhepatoidadenocarcinomaacasereportandreviewoftheliterature AT jianghuifeng primarypulmonaryhepatoidadenocarcinomaacasereportandreviewoftheliterature AT liqiuyao primarypulmonaryhepatoidadenocarcinomaacasereportandreviewoftheliterature |